![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, February 21, 2014 10:23:30 AM
A rookie ? for folks. Rereading the end of the company statment of the last test, the primary reason for 2nd study was safety and that portion was sucessful. First study also showed no safety or serious issues. The 2% cream worked in both studies but not much better than the placebo? in some people
Continue reading and they state, will meet with FDA and discuss issues going forward for what appears a stronger dose via perscription ??????
Seems they have past all safety issues and the cream works just need stronger dose??
Am I reading to much into this?????
2nd question is how does this qualify for special treatment when oral vs cream? Not the same?
Thanks in advance
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM